Prognostic significance of chromosome 3 alterations determined by microsatellite analysis in uveal melanoma: A long-term follow-up study

British Journal of Cancer

Volumn 106, Issue 6, 2012, Pages 1171-1176

  Thomas, S ^a   Putter C ^b   Weber, S ^a   Bornfeld, N ^a   Lohmann, D R ^a   Zeschnigk, M ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

eye; microsatellite analysis (MSA); monosomy 3; partial monosomy 3; prognosis; uveal melanoma

Indexed keywords

MICROSATELLITE DNA;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; CHROMOSOME 3; CHROMOSOME 8; CHROMOSOME ABERRATION; CLINICAL FEATURE; DISOMY; ENUCLEATION; EPITHELIOID CELL; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; TUMOR VOLUME; UVEA MELANOMA;

AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MELANOMA; MICROSATELLITE REPEATS; MIDDLE AGED; MONOSOMY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; UVEAL NEOPLASMS;

EID: 84858291708     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.54     Document Type: Article

References (22)

1. Abdel-Rahman MH, Christopher BN, Faramawi MF, Said-Ahmed K, Cole C, McFaddin A, Ray-Chaudhury A, Heerema N, Davidorf FH (2011) Frequency, molecular pathology and potential clinical significance of partial chromosome 3 aberrations in uveal melanoma. Mod Pathol 24: 954-962
2. Beran TM, McCannel TA, Stanton AL, Straatsma BR, Burgess BL (2009) Reactions to and desire for prognostic testing in choroidal melanoma patients. J Genet Couns 18: 265-274
3. Cross NA, Ganesh A, Parpia M, Murray AK, Rennie IG, Sisley K (2006) Multiple locations on chromosome 3 are the targets of specific deletions in uveal melanoma. Eye (Lond) 20: 476-481
4. Damato B, Coupland SE (2009) Translating uveal melanoma cytogenetics into clinical care. Arch Ophthalmol 127: 423-429
5. Damato B, Dopierala JA, Coupland SE (2010) Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification. Clin Cancer Res 16: 6083-6092
6. Grambsch P, Therneau T (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81: 515-526
7. Kujala E, Makitie T, Kivela T (2003) Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci 44: 4651-4659 (Pubitemid 37315273)
8. Lake SL, Coupland SE, Taktak AF, Damato BE (2010) Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma. Invest Ophthalmol Vis Sci 51: 4884-4891
9. McLean IW, Foster WD, Zimmerman LE (1982) Uveal melanoma: location, size, cell type, and enucleation as risk factors in metastasis. Hum Pathol 13: 123-132 (Pubitemid 12131098)
10. Onken MD, Worley LA, Ehlers JP, Harbour JW (2004) Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 64: 7205-7209 (Pubitemid 39372052)
11. Onken MD, Worley LA, Tuscan MD, Harbour JW (2010) An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma. J Mol Diagn 12(4): 461-468
12. Parrella P, Sidransky D, Merbs SL (1999) Allelotype of posterior uveal melanoma: implications for a bifurcated tumour progression pathway. Cancer Res 59: 3032-3037 (Pubitemid 29315995)
13. Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jockel KH, Becher R (1996) Prognostic implications of monosomy 3 in uveal melanoma. Lancet 347: 1222-1225 (Pubitemid 26131850)
14. Sambrook JFT, Maniatis T (1989) In Molecular Cloning, 2nd edn. Cold Spring Harbor Laboratory Press: ColdSpring Harbor, NY
15. Scholes AG, Damato BE, Nunn J, Hiscott P, Grierson I, Field JK (2003) Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival. Invest Ophthalmol Vis Sci 44: 1008-1011 (Pubitemid 36297813)
16. Shields CL, Ganguly A, Bianciotto CG, Turaka K, Tavallali A, Shields JA (2011) Prognosis of uveal melanoma in 500 cases using genetic testing of fine-needle aspiration biopsy specimens. Ophthalmology 118: 396-401
17. Sisley K, Rennie IG, Parsons MA, Jacques R, Hammond DW, Bell SM, Potter AM, Rees RC (1997) Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis. Genes Chromosomes Cancer 19: 22-28 (Pubitemid 27193716)
18. Tschentscher F, Hüsing J, Hölter T, Kruse E, Dresen IG, Jöckel KH, Anastassiou G, Schilling H, Bornfeld N, Horsthemke B, Lohmann DR, Zeschnigk M (2003) Tumour classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. Cancer Res 63: 2578-2584 (Pubitemid 36608917)
19. Tschentscher F, Prescher G, Horsman DE, White VA, Rieder H, Anastassiou G, Schilling H, Bornfeld N, Bartz-Schmidt KU, Horsthemke B, Lohmann DR, Zeschnigk M (2001) Partial deletions of the long and short arm of chromosome 3 point to two tumour suppressor genes in uveal melanoma. Cancer Res 61: 3439-3442 (Pubitemid 32695038)
20. Tschentscher F, Prescher G, Zeschnigk M, Horsthemke B, Lohmann DR (2000) Identification of chromosomes 3, 6, and 8 aberrations in uveal melanoma by microsatellite analysis in comparison to comparative genomic hybridization. Cancer Genet Cytogenet 122: 13-17
21. White VA, Chambers JD, Courtright PD, Chang WY, Horsman DE (1998) Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma. Cancer 83: 354-359 (Pubitemid 28317816)
22. Worley LA, Onken MD, Person E, Robirds D, Branson J, Char DH, Perry A, Harbour JW (2007) Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma. Clin Cancer Res 13(5): 1466-1471 (Pubitemid 46450436)